Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anindita Chakrabarty
Correction: Will PI3K Pathway Inhibitors Be Effective as Single Agents in Patients With Cancer?
Oncotarget
Oncology
Will PI3K Pathway Inhibitors Be Effective as Single Agents in Patients With Cancer?
Oncotarget
Oncology
Related publications
Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer
Oncotarget
Oncology
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Inhibitors of the Fanconi Anaemia Pathway as Potential Antitumour Agents for Ovarian Cancer
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Targeting the PI3K Signaling Pathway in Cancer
Current Opinion in Genetics and Development
Genetics
Developmental Biology
Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
Frontiers in Pharmacology
Pharmacology
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology